Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transdiagnostic behavioral and sociodemographic influences on the cognitive-adaptive functioning gap in neurodivergent children.

Scientific reports·2026
Same author

Short Report: An Examination of Children's Autism Traits and Their Association With Family Experience.

Autism research : official journal of the International Society for Autism Research·2026
Same author

Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8<sup>+</sup> T cells.

Nature biomedical engineering·2026
Same author

Validation of an improved insect bite hypersensitivity severity score for allergic equine insect bite hypersensitivity in horses.

Journal of veterinary internal medicine·2026
Same author

Transition to adulthood in Duchenne Muscular Dystrophy: a systematic review with narrative synthesis on health systems, policies, and the role of health care providers.

Frontiers in public health·2026
Same author

Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.

Frontiers in allergy·2026

Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development
06:04

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development

Published on: December 8, 2023

1.3K

Protamine-Based Strategies for RNA Transfection.

Natalia Teresa Jarzebska1,2, Mark Mellett1,3, Julia Frei1,3

  • 1Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091 Zürich, Switzerland.

Pharmaceutics
|July 2, 2021
PubMed
Summary

Protamine peptide enhances RNA delivery by protecting it from degradation and improving cell penetration. This versatile platform is key for RNA-based therapies and vaccinations, optimizing stability and efficiency.

Keywords:
RNAcancer therapyprotaminetransfectionvaccines

More Related Videos

High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays MEA
09:14

High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays MEA

Published on: September 13, 2012

13.7K
Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

47.8K

Related Experiment Videos

Last Updated: Oct 31, 2025

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development
06:04

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development

Published on: December 8, 2023

1.3K
High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays MEA
09:14

High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays MEA

Published on: September 13, 2012

13.7K
Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

47.8K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Delivery Systems

Background:

  • Protamine, a cationic peptide, is recognized for heparin neutralization and insulin formulations.
  • Its application extends to cellular delivery of nucleic acids via charge-driven interactions.
  • This year celebrates 60 years since Protamine's initial use as a transfection enhancer.

Purpose of the Study:

  • To provide a comprehensive overview of protamine-based RNA delivery strategies.
  • To highlight the optimization of nucleic acid stability and translational efficiency.
  • To discuss the regulation of immunostimulatory properties in protamine-mediated delivery.

Main Methods:

  • Review of early studies and recent developments in protamine-based RNA delivery.
  • Analysis of protamine's dual functionality in RNA stabilization and cellular uptake.
  • Exploration of protamine-based system modifications for targeted delivery and enhanced transfection.

Main Results:

  • Protamine effectively stabilizes RNA against degradation in biological systems.
  • Protamine significantly enhances the penetration of RNA into cells.
  • Protamine-based systems offer flexibility for therapeutic applications, including antibody fusion and polymer mixing.

Conclusions:

  • Protamine is a versatile and effective agent for RNA delivery, crucial for therapeutic applications.
  • Protamine-based RNA delivery systems can be tailored for enhanced stability, efficiency, and targeted delivery.
  • Further development of protamine strategies holds promise for advancing RNA-based vaccines and therapies.